Indefinite Delivery Contract SPE2DX15D9107

The federal contract IDV SPE2DX15D9107 is a single-award Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 IDC, valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. These products support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide across various categories such as injections, tablets, creams, auto-injectors, and specialty medications. As a crucial supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its status as a woman-owned small business to secure direct federal awards for diverse medical products and services, which are not associated with specific set-aside designations.